Topic

Articles

Has Europe&apos;s Innovative Medicines Initiative been successful in alleviating concerns regarding the region?s levels of pharmaceutical innovation?

Can IMI Deliver Real Innovation for Europe?

Jane Wan is a freelance writer based in Singapore.

Quality assurance of biological products is central to India's good distribution practices guidelines.

Report from India

Eastern Europe is moving towards a goal of harmonized regulations.

Navigating Emerging Markets — Eastern Europe

Nathan Jessop reviews the pharmaceutical industry's experience with the first year of Germany?s new pricing policy.

Germany's New Pricing Policy Loses Appeal with Pharma

Domestic companies are changing their business models in response to recent drug price cuts.

Report from South Korea

A Q&A with Yves de Montcheuil, vice-president of marketing at Talend, a provider of open-source integration software.

Q&A with Yves de Montcheuil of Talend

Sean Milmo is a freelance writer based in Essex, UK.

The government of Turkey is drawing up a program in coordination with the pharmaceutical industry to create ways to make the country a regional production center for pharmaceuticals serving Europe, Central Asia, and the Middle East.

Report from Turkey

Foreign firms struggle against stricter patent laws, but all is not lost.

Q&A with David Elder and Richard Wright of Strategic Compliance Consulting, PAREXEL International. Both Elder and Wright formerly served with FDA.

Regulation and Compliance Q&A on 483s

Q&A on GDUFA implementation with Aloka Srinivasan, PhD, a principal consultant with Parexel and former team leader in FDA's Office of Generic Drugs.

Global Perspectives